Facility Design and Engineering

Aug 10, 2018
By BioPharm International Editors
The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec.
Aug 02, 2018
By BioPharm International Editors
The company broke ground on its $200-million, 120,000-sq-ft biomanufacturing plant in West Greenwich, RI.
Jul 17, 2018
By BioPharm International Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 10, 2018
By BioPharm International Editors
The expansion at the company’s Gillingham, UK, site, worth EUR 9 million (approximately US$10.5 million), will improve the company’s distribution capabilities.
Jul 01, 2018
BioPharm International
Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency.
Jun 22, 2018
By BioPharm International Editors
The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.
Jun 21, 2018
By BioPharm International Editors
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
Jun 15, 2018
BioPharm International
Single-use technologies have become increasingly prevalent in final fill/finish operations for biologics.
Jun 07, 2018
By BioPharm International Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
Jun 01, 2018
BioPharm International
Higher cell titers and cell densities have posed a challenge to cell harvesting, a crucial step in biologics manufacturing.
native1_300x100
lorem ipsum